Vantaku, Venkatrao
Putluri, Vasanta
Bader, David A. http://orcid.org/0000-0003-0514-7346
Maity, Suman
Ma, Jing
Arnold, James M.
Rajapakshe, Kimal
Donepudi, Sri Ramya
von Rundstedt, Friedrich-Carl
Devarakonda, Vaishnavi
Dubrulle, Julien
Karanam, Balasubramanyam
McGuire, Sean E.
Stossi, Fabio
Jain, Abhinav K.
Coarfa, Cristian http://orcid.org/0000-0002-4183-4939
Cao, Qi http://orcid.org/0000-0002-5140-3681
Sikora, Andrew G.
Villanueva, Hugo
Kavuri, Shyam M.
Lotan, Yair http://orcid.org/0000-0001-5692-2723
Sreekumar, Arun
Putluri, Nagireddy
Funding for this research was provided by:
American Cancer Society (127430-RSG-15-105-01-CNE)
Article History
Received: 4 March 2019
Revised: 4 April 2019
Accepted: 5 April 2019
First Online: 5 August 2019
Change Date: 17 August 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41388-020-1283-7
Compliance with ethical standards
:
: S.M.K. is stake holder of NeoZenome Therapeutics Inc.